E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPOPIO0004(Opioid peptide)
DFBP ID DFBPOPIO0004
Peptide sequence YIPIQYVLSR
Type Native peptide
Peptide/Function name Opioid peptide, Casoxin C
Function-activity relationship
Main bioactivity Opioid activity
Otheir bioactivity ACE-inhibitory activity [D1], Immunomodulatory activity [D2], Ileum contracting activity [D3], Multifunctional activity [D4]
Calculated physicochemical properties
Three-letter amino acid Tyr-Ile-Pro-Ile-Gln-Tyr-Val-Leu-Ser-Arg
Single-letter amino acid YIPIQYVLSR
Peptide length 10
Peptide mass
Experimental mass Theoretical mass
N.D 1251.47 Da c
Net charge 0.00 c
Isoelectric point (pI) 9.59 c
IC50 N.D
pIC50 N.D
GRAVY 0.4000 c
Hydrophilic residue ratio 50% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Animal
Organism/Source Bovine milk protien [2]
Precursor protein κ-Casein
Residue position f(25-34)
Precursor protein(s) search
Link-research
There are no literature reports on the discovery of this sequence in other food-source proteins.
Biological/Functional activity & target protein
Opioid activity The IC50 value of casoxin C was 50 nM the radioreceptor assay in the presence of 1 nM [3H]naloxone. In the guinea pig ileum assay, the A2 value of casoxin C for μ-selective agonist Tyr-D-Ala-Gly-MePhe-Glyol (DAGO) was 5 μM. As shown in table 1.
Table 1 Opioid antagonist activities of peptide.
Peptide
Receptor assay a, IC50, μM
GPI assay b, A2, μM
References
Casoxin C50
5
Opioid antagonist, this peptide showed a relatively high opioid antagonistic activity in comparison to the esterified peptides (IC50 = 400.0 umol/l) and has been characterized as μ-type ligands.[2]
a Radioreceptor test performed in presence of 1 nM [3H]naloxone.
b Concentration of opioid antagonist to make the IC50 value of μ-receptor specific opioid agonist Tyr-D-Ala-Gly-MePhe-Glyol (DAGO) two-fold in the guinea pig ileum assay.
Specific target protein(s) Specific Target Protein(s):
Mu-type opioid receptor
Taste properties & Structure
Bitterness
Literature report N.D
Bitter prediction tools Bitter taste prediction
SMILES N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)O
Preparation method
Mode of preparation Enzymatic hydrolysis
Enzyme(s)/starter culture

κ-Casein was digested with trypsin at 37 ℃.

Stability & Cytotoxicity
Peptide stability
Literature report: N.D
EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report: N.D
Prediction: ToxinPred
Additional information
Additional information N.D
Database cross-references
DFBP
[D1] DFBPACEI0350
[D2] DFBPIMMU0051
[D3] DFBPICPE0002
[D4] DFBPMUFU0107
BIOPEP-UWM [D5] 3213, 3215, 3216, 3495
APD [D6] -
BioPepDB [D7] -
MBPDB [D8] -
Reference(s)
Primary literature Chiba H, Tani F, Yoshikawa M. Opioid antagonist peptides derived from kappa-casein. J Dairy Res. 1989;56(3):363-6.
PMID: 2760302
Other literature(s)

[1] Park Y W. Bioactive Components in Milk and Dairy Products[M]. 2009.
[2] Meisel H, Fitzgerald R J. Opioid peptides encrypted in intact milk protein sequences.[J]. British Journal of Nutrition, 2000, 84(S1):27-31.
[3] Meisel H. Overview on Milk Protein-derived Peptides[J]. International Dairy Journal, 1998, 8(5–6):363-373.
[4] Kostyra E, Sienkiewiczszłapka E, Jarmołowska B, et al. Opioid peptides derived from milk proteins.[J]. Polish Journal of Food & Nutrition Sciences, 2004.
[5] Yoshikawa M., Tani F., Shiota H., Usuñ H., Suganuma H., Usuñ K., Kurahashi K., Chiba H., Casoxin D an opioid antagonist/ileum-contracting/vasorelaxing peptide derived from human αs1-casein. 1994, in: β-Casomorphins and Related Peptides: Recent Developments (eds. Brantl V., Teschemacher H.). VCH, Weinheim, pp. 43–48.

PubDate 1989
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214